Chronic pain and depression occur together in a third to half of pain patients and worsen each other through shared brain pathways. Treatment pairs an antidepressant that also reduces pain signaling, usually an SNRI such as duloxetine, with cognitive behavioral therapy for pain and sleep. Most patients improve within six to eight weeks; TMS and Spravato remain available.
At Stedfast Psychiatry we treat the mood side of chronic pain as a medical problem in its own right, not as a reaction you are expected to tolerate. We choose antidepressants that also reduce pain signaling, we use cognitive behavioral therapy built for people who hurt, we repair the sleep that pain destroys, and we coordinate with your pain specialist, rheumatologist or primary care physician so no one is working against anyone else. When depression has not responded to medication, Deep TMS and Spravato are available in the same practice.
Symptoms of pain and depression
- Low mood, hopelessness or loss of interest that has set in alongside months of pain
- Pain that feels more intense, more widespread or harder to ignore on bad mood days
- Poor sleep, either trouble falling asleep because of pain or waking unrefreshed
- Fatigue and low energy that is out of proportion to the physical condition
- Withdrawing from work, hobbies and social contact because of pain or the fear of pain
- Irritability, anxiety or a sense of being a burden to family
- Trouble concentrating, often called fibro fog or pain fog
- Thoughts that life is not worth living with the pain, which always warrant urgent evaluation
Causes and risk factors
Pain and mood are processed by overlapping brain regions, including the anterior cingulate cortex, insula, prefrontal cortex and amygdala, and both depend on the same chemical messengers. Serotonin and norepinephrine run the descending pathways that dampen pain signals coming up the spinal cord. When depression lowers activity in those pathways, the same injury produces more pain. Chronic pain also keeps the stress system switched on, raises inflammatory signaling and disrupts sleep, each of which independently raises the risk of depression.
The relationship runs in both directions and is strongest in conditions where the nervous system itself has become sensitized: fibromyalgia, chronic low back pain, migraine, irritable bowel syndrome, temporomandibular disorders and neuropathic pain after shingles or diabetes. Opioid therapy adds a layer. Long-term opioids can blunt mood, worsen sleep apnea and produce a withdrawal-driven low that mimics depression between doses. A history of trauma or early adversity makes both chronic pain and depression more likely and more entangled.
About 20.9 percent of US adults, roughly 51.6 million people, had chronic pain in 2021, and 6.9 percent had high-impact chronic pain that limited daily life or work.
Source: CDC Morbidity and Mortality Weekly Report, Rikard et al., 2023
Depression is present in roughly 30 to 50 percent of patients treated in pain clinics, and the combination produces worse outcomes for both conditions than either alone.
Source: Bair et al., Archives of Internal Medicine, 2003
Duloxetine holds FDA approval for major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia and chronic musculoskeletal pain.
Source: FDA prescribing information for duloxetine (Cymbalta)
Psychological therapies for chronic pain, led by CBT, produce small but reliable improvements in pain, disability and distress that persist after treatment ends.
Source: Williams et al., Cochrane Database of Systematic Reviews, 2020
How we diagnose it at Stedfast Psychiatry
We start with a structured psychiatric interview that treats your pain history as part of the story rather than someone else's department. We ask when the pain began, what has been tried, which medications you take and how your mood, sleep, appetite and activity have changed since. We use the PHQ-9 for depression, the GAD-7 for anxiety, the Insomnia Severity Index for sleep, and the PEG scale (pain intensity, enjoyment of life, general activity) to quantify how much pain is interfering with daily life. When symptoms suggest it, we screen for PTSD, bipolar disorder and substance use, because each changes the medication plan.
We review every medication for mood effects: opioids, gabapentinoids, muscle relaxants, benzodiazepines and corticosteroids can all lower mood or cloud thinking. We check thyroid function, vitamin D, B12 and a complete blood count when they have not been done recently, and we request records from your pain or rheumatology team. Somatic symptom disorder, where the distress about pain is out of proportion to findings, is a separate diagnosis that calls for a different emphasis in therapy; we make that distinction carefully and without implying the pain is imagined.
Treatment options
Medication management
Our first-line choice is usually a serotonin-norepinephrine reuptake inhibitor, because this class treats depression and pain through the same mechanism. Duloxetine (Cymbalta) is FDA-approved for major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia and chronic musculoskeletal pain including low back pain and osteoarthritis, which makes it the most versatile single agent for this combination. We start at 30 mg for one to two weeks and move to 60 mg; mood benefit usually appears by four to six weeks and pain benefit often sooner. Venlafaxine XR is an alternative with similar dual action. Milnacipran (Savella) is approved for fibromyalgia but not for depression in the United States, so we pair it with other treatment when mood is the main target. Low-dose tricyclics such as nortriptyline or amitriptyline at 10 to 50 mg at bedtime remain useful for neuropathic pain, headache prevention and sleep, and can be combined carefully with an SNRI. SSRIs treat depression well but have weaker pain data, so we reserve them for patients who cannot tolerate SNRIs. We check blood pressure on SNRIs, monitor sodium in older adults, and avoid combining serotonergic antidepressants with tramadol or high-dose cyclobenzaprine because of serotonin syndrome risk. If you take opioids, we coordinate with the prescriber rather than changing that regimen ourselves, and we never combine opioids with benzodiazepines.
Psychotherapy
Cognitive behavioral therapy for chronic pain (CBT-CP) is the best-studied psychological treatment for this combination. It does not ask you to think the pain away. It teaches pacing so activity no longer swings between overdoing and collapse, replaces catastrophic predictions about pain with accurate ones, rebuilds valued activity step by step, and treats the fear of movement that keeps muscles deconditioned. Acceptance and commitment therapy is an equally supported alternative that focuses on living fully with pain present. When pain has wrecked sleep, we add CBT for insomnia, because better sleep lowers next-day pain ratings. Our therapists coordinate with your prescriber so medication changes and therapy goals move together.
Interventional options
When depression persists after two or more adequate antidepressant trials, Deep TMS at our Palm Beach Gardens office is an FDA-cleared, non-drug option that does not interact with pain medications. Early research also suggests TMS over the motor cortex can reduce certain chronic pain conditions, though that use is not FDA-cleared and we do not market it as pain treatment. Spravato (esketamine) nasal spray, FDA-approved for treatment-resistant depression, is offered at Boynton Beach, Palm Beach Gardens and Royal Palm Beach. Both can be used while you continue care with your pain specialist.
What to expect
Your first visit is a 45 to 60 minute evaluation, in person at any of our Florida or South Carolina offices or by video. We will ask you to bring your current medication list, including over-the-counter and pain medications, and the names of the physicians treating your pain. You leave with a written plan that typically includes an antidepressant chosen for dual mood and pain benefit, a referral to one of our therapists for CBT-CP, and specific sleep recommendations. Follow-ups at two to four weeks and then every four to eight weeks let us adjust dose, track PHQ-9 and PEG scores, and coordinate with your other physicians. Most ongoing care is well suited to telehealth, which matters when travel itself is painful.
When to seek help
Make an appointment if low mood, hopelessness or loss of interest has lasted more than two weeks alongside your pain, if you have stopped doing things you could still physically do, or if you find yourself relying on alcohol, cannabis or extra doses of pain medication to get through the day. Seek help sooner if sleep has collapsed or if your pain physician has raised concern about your mood. If you have thoughts that you would be better off dead or of ending your life, call or text 988, the Suicide and Crisis Lifeline, or go to the nearest emergency room. Chronic pain raises suicide risk, and that risk is treatable.
Which pain conditions carry the highest depression risk
Depression can accompany any lasting pain, but some conditions are especially entangled with mood. Fibromyalgia involves central sensitization, a state in which the nervous system amplifies normal signals, and rates of depression and anxiety are among the highest of any pain condition. Chronic low back pain is the most common source of disability in working-age adults and the pain condition most often seen alongside depression in primary care. Migraine and chronic daily headache share serotonin biology with mood disorders. Neuropathic pain from diabetes, shingles or chemotherapy responds specifically to the antidepressants we use. Irritable bowel syndrome, interstitial cystitis and temporomandibular disorders cluster with anxiety and depression and often respond to the same combined approach.
Depression, somatic symptom disorder and malingering are not the same thing
Patients with chronic pain are sometimes treated as if their pain is exaggerated or invented. We draw the lines carefully. Depression with chronic pain means a genuine mood disorder alongside a genuine pain condition. Somatic symptom disorder means that worry and preoccupation about the pain have become disabling beyond what the pain itself would cause; it is common, treatable with therapy, and not a sign that the pain is fake. Malingering, the deliberate production of symptoms for external gain, is rare and is not something we assume. Getting the diagnosis right determines whether the emphasis belongs on antidepressant selection, on therapy for health anxiety, or on both.
The sleep piece
Pain fragments sleep, and fragmented sleep lowers the pain threshold the next day in a cycle that can be measured in the laboratory. Many pain patients are prescribed sedating medications that make the problem worse over time: benzodiazepines and zolpidem lose effect, suppress deep sleep and raise fall and overdose risk. We prefer CBT for insomnia as the foundation, with sedating antidepressants such as low-dose doxepin, trazodone or mirtazapine when a medication is needed, and we screen for sleep apnea, which is common in patients on opioids and in those who have gained weight through inactivity.
Lifestyle and self-management that actually help
- Graded activity: small, scheduled increases in walking or stretching, planned rather than driven by how the day feels, rebuild tolerance without flares.
- Anti-inflammatory basics: regular meals, limited alcohol, no smoking, and attention to weight reduce the inflammatory load that worsens both pain and mood.
- Social contact: isolation deepens depression and increases pain focus; keeping even brief regular contact with people is treatment, not a luxury.
- Pacing, not pushing: the pattern of doing too much on good days and collapsing afterward is the single most common habit CBT for pain corrects.
Prognosis
With combined treatment, most patients see depression improve substantially within two to three months, and that improvement makes physical rehabilitation more achievable. Pain intensity usually improves by a moderate amount rather than disappearing; the larger change is in function, sleep and how much of life the pain controls. Depression that returns tends to do so during pain flares, surgery or loss of work, which is why we keep follow-up open and recommend continuing an effective antidepressant for at least a year after recovery. Patients whose depression has not responded to two or more medications have interventional options in the same practice, and we do not consider any patient's mood untreatable because their pain is chronic.
Frequently asked questions
Is my depression just a reaction to the pain?
Partly, but that does not make it less real or less treatable. Pain and depression share brain pathways and chemistry, which is why the same medications work on both and why treating the depression usually lowers pain scores too. Waiting for the pain to resolve before treating the mood often means waiting indefinitely. We treat both at once, and in most patients function improves faster than pain intensity does, which is the outcome that matters most for daily life.
Will an antidepressant help my pain, or only my mood?
SNRIs such as duloxetine and venlafaxine, and low-dose tricyclics such as nortriptyline, reduce pain signaling through the descending serotonin and norepinephrine pathways in the spinal cord. That effect is independent of mood and often appears within one to two weeks, before the antidepressant effect. SSRIs are good antidepressants but weaker pain relievers. The pain reduction is usually moderate rather than complete, so we pair medication with CBT for pain and, where appropriate, physical therapy.
I take opioids. Can you still prescribe antidepressants?
Yes, with a few precautions. Tramadol, tapentadol and meperidine have serotonergic activity and need care when combined with SNRIs or SSRIs; we coordinate doses with your pain prescriber. We will not prescribe benzodiazepines alongside opioids because the combination raises overdose risk. We will also discuss honestly whether long-term opioids may be contributing to low mood, poor sleep and reduced pain tolerance, and if a taper makes sense we support it in partnership with your pain physician rather than on our own.
What is CBT for chronic pain and does it mean the pain is in my head?
No. All pain is processed in the brain, which is why psychological treatment can change it, but that is different from saying it is imagined. CBT for chronic pain teaches activity pacing, breaks the cycle of flare and collapse, treats fear of movement, improves sleep and replaces catastrophic thinking with accurate expectations. Studies show it reduces disability and distress and modestly reduces pain itself. Typical courses run eight to twelve sessions, in person or by telehealth.
How long before I feel better?
Pain relief from an SNRI or tricyclic often starts within one to two weeks. Mood improvement usually takes four to six weeks at a therapeutic dose, with the full effect by eight to twelve weeks. Sleep improvements from CBT for insomnia appear within a few weeks. We track PHQ-9 and PEG scores at each visit so that progress is measured rather than guessed, and we change course if a medication has not helped by eight weeks.
What does treatment cost and is it covered by insurance?
Psychiatric evaluation and medication management for depression are covered by most major insurance plans and by Medicare, usually with a specialist copay. Psychotherapy is covered under mental health benefits. Self-pay new-patient visits are $185. Deep TMS and Spravato for treatment-resistant depression require prior authorization and have separate coverage criteria that our coordinators verify before you start. The antidepressants we use for pain and mood, including generic duloxetine, are inexpensive.
Can I do this by telehealth?
Yes. Evaluation, medication management and CBT for chronic pain all work well by secure video for patients anywhere in Florida or South Carolina, and we encourage it when driving or sitting in a waiting room is painful. Certain controlled substances have prescribing limits by telehealth, and TMS and Spravato are in-office treatments, but the core of pain-and-depression care can be delivered from home.
If medications have failed, what else is there?
Deep TMS, an FDA-cleared non-drug treatment, is available at our Palm Beach Gardens office for depression that has not responded to medication, and it does not interact with pain medications. Spravato nasal spray is FDA-approved for treatment-resistant depression and is offered at three of our Florida offices. Augmentation strategies such as adding bupropion, lithium or an atypical antipsychotic to an SNRI are also options. Failing one or two medications does not mean the depression cannot be treated.
Where to get treatment for chronic pain and depression
Evaluation and treatment for chronic pain and depression is available at every Stedfast Psychiatry office and by video across Florida and South Carolina.
Related conditions
If you are thinking about harming yourself, call or text 988 now, or go to the nearest emergency room. This page is educational and does not replace an evaluation. Clinical content reviewed by Dr. David Husted, board-certified psychiatrist.